Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Flow-mediated Vasodilatation (FMD)”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Testing effectiveness (Phase 2)Study completedNCT00277875
What this trial is testing

STRETCH Study: Effect of Distensibility on Endothelial-Dependent Vasoreactivity in Patients With ISH

Who this might be right for
Cardiovascular Disease
Synvista Therapeutics, Inc 25
Post-approval studies (Phase 4)Ended earlyNCT02798068
What this trial is testing

Steroids and Microcirculation In Cardiac Surgery

Who this might be right for
C.Surgical ProcedureCardiac
Erasme University Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00302250
What this trial is testing

The STRETCH Study: Distensibility on Endothelial-Dependent Vasoreactivity in Subjects With Systolic Hypertension

Who this might be right for
Cardiovascular Disease
Synvista Therapeutics, Inc 70
Not applicableUnknownNCT00949195
What this trial is testing

Pulmonary Arterial Pressure Response During Exercise

Who this might be right for
COPD PatientsHealthy SubjectsSemi-supine Echo (SSE)+2 more
Szeged University 80
Early research (Phase 1)Study completedNCT01703286
What this trial is testing

Trial to Assess the Influence of 4 Weeks' Treatment With Linagliptin as Compared to Glimepiride and Placebo on Endothelial Function in Patients With Type 2 Diabetes Using FMD (Flow-Mediated Vasodilation)

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 42
Very early researchLooking for participantsNCT06609356
What this trial is testing

Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Diabetes

Who this might be right for
Type 1 Diabetes MellitusGlucokinase-Maturity Onset Diabetes of the Young (GCK-MODY)MODY2 Diabetes+1 more
Vanderbilt University Medical Center 27